Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
1.
Int J Mol Sci ; 24(5)2023 Feb 27.
Article in English | MEDLINE | ID: mdl-36902068

ABSTRACT

Phloroglucinol is a class of polyphenolic compounds containing aromatic phenyl rings and is known to have various pharmacological activities. Recently, we reported that this compound isolated from Ecklonia cava, a brown alga belonging to the family Laminariaceae, has potent antioxidant activity in human dermal keratinocytes. In this study, we evaluated whether phloroglucinol could protect against hydrogen peroxide (H2O2)-induced oxidative damage in murine-derived C2C12 myoblasts. Our results revealed that phloroglucinol suppressed H2O2-induced cytotoxicity and DNA damage while blocking the production of reactive oxygen species. We also found that phloroglucinol protected cells from the induction of apoptosis associated with mitochondrial impairment caused by H2O2 treatment. Furthermore, phloroglucinol enhanced the phosphorylation of nuclear factor-erythroid-2 related factor 2 (Nrf2) as well as the expression and activity of heme oxygenase-1 (HO-1). However, such anti-apoptotic and cytoprotective effects of phloroglucinol were greatly abolished by the HO-1 inhibitor, suggesting that phloroglucinol could increase the Nrf2-mediated activity of HO-1 to protect C2C12 myoblasts from oxidative stress. Taken together, our results indicate that phloroglucinol has a strong antioxidant activity as an Nrf2 activator and may have therapeutic benefits for oxidative-stress-mediated muscle disease.


Subject(s)
Antioxidants , Oxidative Stress , Phaeophyceae , Phloroglucinol , Animals , Humans , Mice , Antioxidants/pharmacology , Apoptosis , Cell Line , Heme Oxygenase-1/metabolism , Hydrogen Peroxide/metabolism , Myoblasts/metabolism , NF-E2-Related Factor 2/metabolism , Oxidative Stress/drug effects , Phaeophyceae/metabolism , Phloroglucinol/pharmacology , Reactive Oxygen Species/metabolism
2.
Mar Drugs ; 20(12)2022 Dec 10.
Article in English | MEDLINE | ID: mdl-36547921

ABSTRACT

Insomnia is a common sleep disorder. Natural sleep aids are gaining worldwide popularity as alternatives to prescription drugs for improving sleep. Recently, numerous studies have investigated the sedative-hypnotic effects of the polyphenols of terrestrial plants. The hypnotic effects of marine polyphenols have also been studied in recent years. Phlorotannins are marine polyphenols that are found only in brown algae. Phlorotannins exert sedative-hypnotic effects via the gamma-aminobutyric acid type A-benzodiazepine receptor. In addition, the brown seaweed Ecklonia cava supplement containing phlorotannins has been approved by the Ministry of Food and Drug Safety as a health-functional ingredient that helps improve sleep quality. Currently, it is meaningful to deal with the sedative-hypnotic effects of phlorotannins as natural sleep aids. The current review comprehensively presents the sedative-hypnotic effects in animal models and human clinical trials as well as their mechanism of action, extraction, purification, and safety.


Subject(s)
Phaeophyceae , Seaweed , Sleep Initiation and Maintenance Disorders , Animals , Humans , Polyphenols/pharmacology , Polyphenols/therapeutic use , Sleep Initiation and Maintenance Disorders/drug therapy , Hypnotics and Sedatives/pharmacology , Hypnotics and Sedatives/therapeutic use , Sleep
3.
Nutr Neurosci ; 24(11): 835-842, 2021 Nov.
Article in English | MEDLINE | ID: mdl-31650903

ABSTRACT

Phlorotannin supplement (PS) is a natural hypnotic substrate that modulates γ-aminobutyric acid type A (GABAA)-benzodiazepine (BZD) receptors. However, there is a lack of functional data assessing the role of individual components of PS, such as Dieckol, as allosteric activators of GABAA receptors (GABAAR). Using the whole cell patch clamp technique, we demonstrated that PS functionally enhanced the activity of GABAA-BZD receptors in a heterologous system and in primary cultured neurons. Application of diazepam (DZP) or Dieckol (1) increased GABAAR-mediated inward current in HEK293T cells containing the α1 subunit in a dose-dependent manner, (2) which was blocked by co-treatment with the selective benzodiazepine site antagonist, flumazenil (FLZ); it also (3) increased the amplitude of GABAA-BZD receptors in primary cultured neurons, which was blocked by FLZ and (4) attenuated spontaneous activity in cultured neurons. These results indicate that PS and Dieckol act as positive allosteric activators of GABAA-BZD receptors, which might be the underlying mechanism of the sedative-hypnotic effect of PS. To our knowledge, this is the first study to directly link Dieckol-induced GABAAR activation via the BZD site binding and suppression of spontaneous neuronal activity in vitro.


Subject(s)
Neurons , Receptors, GABA-A , Benzofurans , HEK293 Cells , Humans , Neurons/metabolism , Receptors, GABA-A/metabolism , gamma-Aminobutyric Acid/pharmacology
4.
J Enzyme Inhib Med Chem ; 36(1): 831-846, 2021 Dec.
Article in English | MEDLINE | ID: mdl-33752569

ABSTRACT

Small molecule modulators of mitochondrial function have been attracted much attention in recent years due to their potential therapeutic applications for neurodegenerative diseases. The mitochondrial translocator protein (TSPO) is a promising target for such compounds, given its involvement in the formation of the mitochondrial permeability transition pore in response to mitochondrial stress. In this study, we performed a ligand-based pharmacophore design and virtual screening, and identified a potent hit compound, 7 (VH34) as a TSPO ligand. After validating its biological activity against amyloid-ß (Aß) induced mitochondrial dysfunction and in acute and transgenic Alzheimer's disease (AD) model mice, we developed a library of analogs, and we found two most active compounds, 31 and 44, which restored the mitochondrial membrane potential, ATP production, and cell viability under Aß-induced mitochondrial toxicity. These compounds recovered learning and memory function in acute AD model mice with improved pharmacokinetic properties.


Subject(s)
Alzheimer Disease/drug therapy , Mitochondria/drug effects , Neuroprotective Agents/pharmacology , Protein Aggregation, Pathological/drug therapy , Small Molecule Libraries/pharmacology , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/antagonists & inhibitors , Amyloid beta-Peptides/metabolism , Animals , Cell Survival/drug effects , Cells, Cultured , Disease Models, Animal , Drug Evaluation, Preclinical , Humans , Ligands , Mice , Mitochondria/metabolism , Molecular Structure , Neuroprotective Agents/chemical synthesis , Neuroprotective Agents/chemistry , Protein Aggregation, Pathological/metabolism , Protein Aggregation, Pathological/pathology , Small Molecule Libraries/chemical synthesis , Small Molecule Libraries/chemistry , Transcriptional Regulator ERG/antagonists & inhibitors , Transcriptional Regulator ERG/metabolism
5.
Biosci Biotechnol Biochem ; 82(2): 320-328, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29307270

ABSTRACT

Although rice bran consumption is reportedly has numerous beneficial effects on human health, the relationship between rice bran and the prevention of photoaging has not been investigated in detail. We sought to investigate whether consumption of rice bran supplement (RBS) can elicit preventive effects against UVB-induced photoaging in vivo. Dorsal skin sections of hairless mice were exposed to UVB over 16 weeks. RBS consumption suppressed UVB-induced wrinkle formation and inhibited the loss of water content and epidermal thickening in the mouse skin. Western blot and immunohistochemical analyses revealed that repeated exposure to UVB upregulated matrix metalloproteinase-13 (MMP-13) and cyclooxygenase-2 (COX-2) expression, while consumption of RBS suppressed MMP-13 and COX-2 expression, as well as mitogen-activated protein kinase (MAPK) signaling pathways. These findings suggest that RBS could be a potential bioactive ingredient in nutricosmetics to inhibit wrinkle formation and water content loss via the suppression of COX-2 and MMP-13 expression.


Subject(s)
Dietary Supplements , Oryza/chemistry , Skin Aging/drug effects , Skin Aging/radiation effects , Ultraviolet Rays/adverse effects , Animals , Cyclooxygenase 2/metabolism , Epidermis/drug effects , Epidermis/pathology , Epidermis/radiation effects , Female , Gene Expression Regulation, Enzymologic/drug effects , Gene Expression Regulation, Enzymologic/radiation effects , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/radiation effects , Matrix Metalloproteinase 13/metabolism , Mice , Skin Aging/pathology , Water/metabolism
6.
Metab Brain Dis ; 33(6): 1877-1886, 2018 12.
Article in English | MEDLINE | ID: mdl-30229385

ABSTRACT

Dried Citrus unshiu peel, also known as Chinpi, have been commonly used as a traditional medicine to improve for allergy, inflammation and hepatopathy. Many previously studies have reported that citrus flavonoids show neuroprotective activities. However, the antidepressant-related effects of C. unshiu peels have not been well characterized. Here, the antidepressant-like effects of standardized C. unshiu peel extract (SCP) were evaluated in in vivo and in vitro depression models induced by dexamethasone (DEX), a synthetic glucocorticoid. Male ICR mice (9-week-old) were injected the DEX (40 mg/kg) and were orally given SCP daily (30, 100, and 300 mg/kg) for 14 consecutive days. The depressive-like behaviors were determined by use of open filed test (OFT), sucrose preference test (SPT), tail suspension test (TST), and forced swim test (FST). We show that treatment with SCP significantly alleviated DEX-induced depressive-like behaviors and reduced neurotoxicity in a concentration dependent manner in SH-SY5Y cells. Additionally, repeated DEX injection markedly decreased brain derived neurotrophic factor (BDNF) level, tropomyosin receptor kinase B (TrkB), and cyclic AMP-response element-binding protein (CREB), while SCP treatment improved these levels in the cerebral cortex and hippocampus regions. Our findings suggest that SCP exhibits significant antidepressant-like effects in the DEX-induced depressive animal model, and this activity may be mediated by preventing corticosterone-induced neurotoxicity.


Subject(s)
Antidepressive Agents/therapeutic use , Citrus , Depression/chemically induced , Depression/drug therapy , Dexamethasone/toxicity , Plant Extracts/therapeutic use , Animals , Antidepressive Agents/isolation & purification , Cell Line, Tumor , Cell Survival/drug effects , Cell Survival/physiology , Corticosterone/blood , Depression/blood , Depression/psychology , Dose-Response Relationship, Drug , Humans , Male , Mice , Mice, Inbred ICR , Plant Extracts/isolation & purification , Swimming/psychology
7.
Mar Drugs ; 16(5)2018 Apr 24.
Article in English | MEDLINE | ID: mdl-29695101

ABSTRACT

In our previous studies, we have demonstrated that marine polyphenol phlorotannins promote sleep through the benzodiazepine site of the gamma-aminobutyric acid type A (GABAA) receptors. In this follow-up study, the sleep-promoting effects of triphlorethol A, one of the major phlorotannin constituents, were investigated. The effect of triphlorethol A on sleep-wake architecture and profiles was evaluated based on electroencephalogram and electromyogram data from C57BL/6N mice and compared with the well-known hypnotic drug zolpidem. Oral administration of triphlorethol A (5, 10, 25, and 50 mg/kg) dose-dependently decreased sleep latency and increased sleep duration during pentobarbital-induced sleep in imprinting control region mice. Triphlorethol A (50 mg/kg) significantly decreased sleep latency and increased the amount of non-rapid eye movement sleep (NREMS) in C57BL/6N mice, without affecting rapid eye movement sleep (REMS). There was no significant difference between the effects of triphlorethol A at 50 mg/kg and zolpidem at 10 mg/kg. Triphlorethol A had no effect on delta activity (0.5⁻4 Hz) of NREMS, whereas zolpidem significantly decreased it. These results not only support the sleep-promoting effects of marine polyphenol phlorotannins, but also suggest that the marine polyphenol compound triphlorethol A is a promising structure for developing novel sedative hypnotics.


Subject(s)
Phloroglucinol/analogs & derivatives , Seaweed/chemistry , Sleep Latency/drug effects , Sleep Stages/drug effects , Administration, Oral , Animals , Dose-Response Relationship, Drug , Hypnotics and Sedatives/chemistry , Hypnotics and Sedatives/pharmacology , Male , Mice , Mice, Inbred C57BL , Mice, Inbred ICR , Molecular Structure , Phloroglucinol/administration & dosage , Phloroglucinol/chemistry , Phloroglucinol/pharmacology , Pyridines/chemistry , Pyridines/pharmacology , Zolpidem
8.
Phytother Res ; 32(4): 698-704, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29368365

ABSTRACT

Our previous study demonstrated that phlorotannin supplement had a sleep-promoting effect in rodents. In the present study, we investigated whether the phlorotannin supplement could improve sleep in subjects with self-reported sleep disturbances. In a randomized, double-blind, placebo-controlled trial, 24 subjects consumed either a placebo or phlorotannin supplement (500 mg/day) for 1 week, 30-60 min prior to bedtime. Sleep parameters were assessed at baseline and at 1 week with sleep questionnaires and polysomnography. At the end of the treatment period, the complete sets of sleep parameters from 20 subjects. Phlorotannin resulted in a significant increase in "Sleep duration" scores compared to the placebo (p = .044), although there were no significant differences on the total PSQI scores. Polysomnography revealed that wakefulness after sleep onset was significantly lower in the phlorotannin group compared to the placebo group (phlorotannin vs. placebo, -25.5 ± 30.5 vs. -1.7 ± 14.9; p = .045) as well as total wake time (phlorotannin vs. placebo, -0.9 ± 3.0 vs. -6.1 ± 6.8; p = .048). Additionally, the respiratory disturbance index during supine rapid eye movement sleep was significantly lower in the phlorotannin group (p = .035). There were no serious adverse effects in either group. Our data suggest that the phlorotannin supplement improved sleep maintenance (WHO ICTRP: KCT0001892).


Subject(s)
Dietary Supplements/adverse effects , Polysomnography/methods , Sleep Initiation and Maintenance Disorders/etiology , Sleep/drug effects , Adult , Double-Blind Method , Female , Humans , Male , Self Report , Surveys and Questionnaires , Treatment Outcome
9.
Mol Pharmacol ; 90(5): 530-539, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27573669

ABSTRACT

α-Pinene is a major monoterpene of the pine tree essential oils. It has been reported that α-pinene shows anxiolytic and hypnotic effects upon inhaled administration. However, hypnotic effect by oral supplementation and the molecular mechanism of α-pinene have not been determined yet. By combining in vivo sleep behavior, ex vivo electrophysiological recording from brain slices, and in silico molecular modeling, we demonstrate that (-)-α-pinene shows sleep enhancing property through a direct binding to GABAA-benzodiazepine (BZD) receptors by acting as a partial modulator at the BZD binding site. The effect of (-)-α-pinene on sleep-wake profiles was evaluated by recording electroencephalogram and electromyogram. The molecular mechanism of (-)-α-pinene was investigated by electrophysiology and molecular docking study. (-)-α-pinene significantly increased the duration of non-rapid eye movement sleep (NREMS) and reduced the sleep latency by oral administration without affecting duration of rapid eye movement sleep and delta activity. (-)-α-pinene potentiated the GABAA receptor-mediated synaptic response by increasing the decay time constant of sIPSCs in hippocampal CA1 pyramidal neurons. These effects of (-)-α-pinene on sleep and inhibitory synaptic response were mimicked by zolpidem, acting as a modulator for GABAA-BZD receptors, and fully antagonized by flumazenil, an antagonist for GABAA-BZD receptor. (-)-α-pinene was found to bind to aromatic residues of α1- and -γ2 subunits of GABAA-BZD receptors in the molecular model. We conclude that (-)-α-pinene enhances the quantity of NREMS without affecting the intensity of NREMS by prolonging GABAergic synaptic transmission, acting as a partial modulator of GABAA-BZD receptors and directly binding to the BZD binding site of GABAA receptor.


Subject(s)
Benzodiazepines/metabolism , Eye Movements/drug effects , Monoterpenes/pharmacology , Pinus/chemistry , Plant Oils/pharmacology , Receptors, GABA-A/metabolism , Sleep/drug effects , Animals , Bicyclic Monoterpenes , Binding Sites , Flumazenil/chemistry , Flumazenil/pharmacology , Inhibitory Postsynaptic Potentials/drug effects , Male , Mice, Inbred C57BL , Mice, Inbred ICR , Models, Molecular , Monoterpenes/chemistry , Pentobarbital , Pyridines/chemistry , Pyridines/pharmacology , Sleep, REM/drug effects , Time Factors , Wakefulness/drug effects , Zolpidem
10.
Molecules ; 21(3): 277, 2016 Feb 27.
Article in English | MEDLINE | ID: mdl-26927055

ABSTRACT

Lindera obtusiloba extracts are commonly used as an alternative medicine due to its numerous health benefits in Korea. However, the antidepressant-like effects of L. obtusiloba extracts have not been fully elucidated. In this study, we aimed to determine whether L. obtusiloba extracts exhibited antidepressant-like activity in rats subjected to forced swim test (FST)-induced depression. Acute treatment of rats with L. obtusiloba extracts (200 mg/kg, p.o.) significantly reduced immobility time and increased swimming time without any significant change in climbing. Rats treated with L. obtusiloba extracts also exhibited a decrease in the limbic hypothalamic-pituitary-adrenal (HPA) axis response to the FST, as indicated by attenuation of the corticosterone response and decreased c-Fos immunoreactivity in the hippocampus CA3 region. In addition, L. obtusiloba extracts, at concentrations that were not affected by cell viability, significantly decreased luciferase activity in response to cortisol in a concentration-dependent manner by the glucocorticoid binding assay in HeLa cells. Our findings suggested that the antidepressant-like effects of L. obtusiloba extracts were likely mediated via the glucocorticoid receptor (GR). Further studies are needed to evaluate the potential of L. obtusiloba extracts as an alternative therapeutic approach for the treatment of depression.


Subject(s)
Antidepressive Agents/pharmacology , Behavior, Animal/drug effects , Depression/drug therapy , Lindera/chemistry , Plant Extracts/pharmacology , Animals , Antidepressive Agents/chemistry , Antidepressive Agents/therapeutic use , Depression/etiology , Depression/physiopathology , Disease Models, Animal , HeLa Cells , Humans , Hypothalamo-Hypophyseal System/drug effects , Male , Pituitary-Adrenal System/drug effects , Plant Extracts/chemistry , Plant Extracts/therapeutic use , Rats , Receptors, Glucocorticoid , Swimming
11.
Molecules ; 21(8)2016 Aug 05.
Article in English | MEDLINE | ID: mdl-27527139

ABSTRACT

In the present study, we examined the ameliorating effects of demethoxycurcumin (DMC) on memory impairment induced by scopolamine using passive avoidance and Morris water maze tests in mice. Moreover, to determine the neurobiological effects underlying the ameliorating effects of the DMC, choline acetyltransferase (ChAT) immunoreactivity was evaluated in mice exposed to scopolamine. Our results demonstrated that chronic oral administration (28 days) of DMC (10 mg/kg) improved scopolamine-induced learning impairment in the passive avoidance task and memory impairment in the Morris water maze. Moreover, Choline acetyltransferase (ChAT) activity in the DMC-treated group was significantly increased to 33.03% compared with the control group. Our present finding suggests that DMC ameliorates memory impairments induced by scopolamine treatment through reversing the reduction of hippocampal ChAT expression in mice.


Subject(s)
Avoidance Learning/drug effects , Curcumin/analogs & derivatives , Maze Learning/drug effects , Memory Disorders/drug therapy , Scopolamine/adverse effects , Administration, Oral , Animals , Choline O-Acetyltransferase/metabolism , Curcumin/administration & dosage , Curcumin/pharmacology , Diarylheptanoids , Disease Models, Animal , Drug Administration Schedule , Gene Expression Regulation/drug effects , Male , Memory Disorders/chemically induced , Memory Disorders/metabolism , Mice , Mice, Inbred ICR
12.
Molecules ; 19(6): 7669-78, 2014 Jun 10.
Article in English | MEDLINE | ID: mdl-24918539

ABSTRACT

The current study was designed to investigate whether edible brown seaweed Ecklonia cava extracts exhibits analgesic effects in plantar incision and spared nerve injury (SNI) rats. To evaluate pain-related behavior, we performed the mechanical withdrawal threshold (MWT) and thermal hypersensitivity tests measured by von Frey filaments and a hot/cold plate analgesia meter. Pain-related behavior was also determined through analysis of ultrasonic vocalization. The results of experiments showed MWT values of the group that was treated with E. cava extracts by 300 mg/kg significantly increased; on the contrary, number of ultrasonic distress vocalization of the treated group was reduced at 6 h and 24 h after plantar incision operation (62.8%, p < 0.05). Moreover, E. cava 300 mg/kg treated group increased the paw withdrawal latency in hot-and cold-plate tests in the plantar incision rats. After 15 days of continuous treatment with E. cava extracts at 300 mg/kg, the treated group showed significantly alleviated SNI-induced hypersensitivity response by MWT compared with the control group. In conclusion, these results suggest that E. cava extracts have potential analgesic effects in the case of postoperative pain and neuropathic pain in rats.


Subject(s)
Pain, Postoperative/drug therapy , Plant Extracts/therapeutic use , Seaweed/chemistry , Animals , Male , Neuralgia/therapy , Rats , Rats, Sprague-Dawley
13.
Food Sci Biotechnol ; 33(6): 1351-1358, 2024 May.
Article in English | MEDLINE | ID: mdl-38585563

ABSTRACT

The rising health consciousness of consumers has resulted in multiple studies on the use of animal and vegetable proteins in gluten-free noodle production, but chicken breast meat (CBM) has not been the subject of such studies. Thus, we aimed to create protein-fortified gluten-free noodles using economical and nutritious CBM and compare their quality attributes with commonly used wheat flour noodles (WN). Among the CBM noodles (CN), CN with tapioca starch (CN-T) showed the highest sensory and textural similarity to WN. The color values of cooked noodles were not considerably different. The water absorption capacity and volume expansion ratio of CN-T were not significantly different from those of WN. In CNs, an ungelatinized microstructure was observed, and CN-T displayed well-formed structural bonds related to adhesiveness, similar to WN. The CN-T had a protein content about 2% higher than WN. This finding is informative for the development of gluten-free noodles using CBM.

14.
Mol Nutr Food Res ; 68(3): e2300253, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38054627

ABSTRACT

SCOPE: Depression is a severe mental condition, common among menopausal women. γ-Oryzanol (ORY) has various biological properties; however, the effect of ORY on menopausal depression and its underlying mechanisms have not been investigated. METHODS AND RESULTS: ORY is orally administered to ovariectomized (OVX) mice for 20 weeks. ORY administration results in lower immobility time in the tail suspension and forced swim test and increases locomotor activity in the open field test. In the primary hippocampal neurons and hippocampi of OVX mice, ORY treatment increases nitric oxide (NO) production and neuronal NO synthase (nNOS) expression. Further, the phosphorylation of extracellular signal-regulated kinase (ERK), cAMP response element-binding protein (CREB), and tropomyosin receptor kinase B, along with the expression of brain-derived neurotrophic factior (BDNF), is upregulated. These stimulatory effects of ORY are diminished by treatment with estrogen receptor ß (ERß) antagonist. ORY similarly interacts with ERß in the molecular docking analysis. Moreover, intracerebroventricular injection of 7-nitroindazole, a nNOS inhibitor, abolishes the antidepressant effects of ORY. CONCLUSIONS: The results indicate that ORY attenuates depressive behavior in OVX mice by upregulating ERß-mediated hippocampal nNOS expression and activating the ERK-CREB-BDNF signaling networks. The findings suggest that ORY is a potential therapeutic agent for attenuating menopausal depression.


Subject(s)
Brain-Derived Neurotrophic Factor , Depression , Phenylpropionates , Mice , Female , Humans , Animals , Depression/drug therapy , Depression/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Estrogen Receptor beta/metabolism , Molecular Docking Simulation , Hippocampus/metabolism , Nitric Oxide Synthase/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Menopause , Nitric Oxide/metabolism
15.
Planta Med ; 79(15): 1408-12, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23975867

ABSTRACT

Flavonoid-rich ethanol extracts of licorice root have sedative and anxiolytic effects. Glabridin is a major flavonoid component from licorice which we evaluated by examining GABA responses in acutely isolated dorsal raphe neurons of the rat. Neurons were recorded with patch-clamp methods at a holding potential of - 50 mV. Glabridin potentiated GABA-induced responses by positively modulating GABAA receptor responses with different concentration range. GABA (2 × 10(-6) M)-evoked currents were potentiated in a stepwise pattern increasing glabridin concentration. Between 10(-12) and 10(-8) M glabridin increased GABA responses by about 140 % of the control. At concentrations above 10(-7) M, a much larger, dose-dependent potentiation occurred before reaching a plateau at 3 × 10-6 M glabridin. A hypnotic drug, zolpidem, also induced biphasic concentration-potentiation relationship. The glabridin potentiation ratio was 2.2 times larger than the maximum potentiation to the benzodiazepine receptor full agonist diazepam. Benzodiazepine receptor antagonist, flumazenil (3 × 10(-7) M), failed to inhibit glabridin (3 × 10(-7) M)-induced potentiation. This result implies that glabridin may exhibit sedative and hypnotic effects by potentiating GABAergic inhibition in dorsal raphe neurons by GABAA receptor actions.


Subject(s)
Brain/drug effects , GABA Agents/pharmacology , Glycyrrhiza/chemistry , Hypnotics and Sedatives/pharmacology , Isoflavones/pharmacology , Phenols/pharmacology , Plant Extracts/pharmacology , Receptors, GABA-A/metabolism , Animals , Anti-Anxiety Agents/pharmacology , Brain/metabolism , Diazepam/pharmacology , Dose-Response Relationship, Drug , Flumazenil/pharmacology , Neurons/drug effects , Neurons/metabolism , Pentobarbital/pharmacology , Plant Roots , Pyridines/pharmacology , Rats , Rats, Sprague-Dawley , Zolpidem , gamma-Aminobutyric Acid/pharmacology
16.
Nutrients ; 15(4)2023 Feb 20.
Article in English | MEDLINE | ID: mdl-36839400

ABSTRACT

Wakefulness is defined as a state in which individuals can react to a change in situations. The number of people staying awake and compensating for lack of sleep has increased in recent years. Caffeine, a representative stimulant, is the most extensively consumed compound globally and is mainly consumed through coffee. Although green tea (Camellia sinensis L.) contains high caffeine content like coffee, its arousal-inducing effects have not yet been studied. In the present study, we aimed to identify the arousal-inducing effect of GT during a chronic administration period (three weeks) using analysis of sleep architecture. Treatment with GT (1500 mg/kg) significantly elevated the sleep latency and wakefulness throughout the treatment period, and chronic administration of GT consistently maintained an increase in wakefulness for up to 3 h. During the treatment period, the arousal-inducing effect of GT (1500 mg/kg) occurred without any change in the tolerance phenomenon or withdrawal symptoms, similar to that observed with caffeine (25 mg/kg). GT (1500 mg/kg) containing 95.6 mg/kg of caffeine did not produce a better arousal-inducing effect than caffeine at 25 mg/kg. These results indicate that the arousal-inducing effect of GT persisted for three weeks without adverse effects and that GT can control the arousal-inducing effects of caffeine due to the hypnotic effects of its other constituents.


Subject(s)
Caffeine , Camellia sinensis , Mice , Animals , Caffeine/pharmacology , Coffee , Ethanol/pharmacology , Sleep , Tea , Central Nervous System Agents , Plant Extracts/pharmacology
17.
Food Funct ; 14(2): 1259, 2023 Jan 23.
Article in English | MEDLINE | ID: mdl-36541786

ABSTRACT

Correction for 'Curcuminoids, a major turmeric component, have a sleep-enhancing effect by targeting the histamine H1 receptor' by Min Young Um et al., Food Funct., 2022, 13, 12697-12706, https://doi.org/10.1039/D2FO02087D.

18.
Antioxidants (Basel) ; 12(10)2023 Oct 10.
Article in English | MEDLINE | ID: mdl-37891920

ABSTRACT

Sargassum horneri, a brown seaweed, is known for its various health benefits; however, there are no reports on its effects on depression. This study aimed to investigate the antidepressant effects of S. horneri ethanol extract (SHE) in mice injected with corticosterone (CORT) and to elucidate the underlying molecular mechanisms. Behavioral tests were conducted, and corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and CORT levels were measured. A fluorometric monoamine oxidase (MAO) enzyme inhibition assay was performed. Neurotransmitters like serotonin, dopamine, and norepinephrine levels were determined. Moreover, the ERK-CREB-BDNF signaling pathway in the prefrontal cortex and hippocampus was evaluated. Behavioral tests revealed that SHE has antidepressant effects by reducing immobility time and increasing time spent in open arms. Serum CRH, ACTH, and CORT levels decreased in the mice treated with SHE, as did the glucocorticoid-receptor expression in their brain tissues. SHE inhibited MAO-A and MAO-B activities. In addition, SHE increased levels of neurotransmitters. Furthermore, SHE activated the ERK-CREB-BDNF pathway in the prefrontal cortex and hippocampus. These findings suggest that SHE has antidepressant effects in CORT-injected mice, via the regulation of the hypothalamic-pituitary-adrenal axis and monoaminergic pathway, and through activation of the ERK-CREB-BDNF signaling pathway. Thus, our study suggests that SHE may act as a natural antidepressant.

19.
Foods ; 12(17)2023 Sep 02.
Article in English | MEDLINE | ID: mdl-37685230

ABSTRACT

Efficient detection methods must be developed for 1,4-dioxane due to its suspected status as a human carcinogen, which is highly mobile in food and environmental resources. In this regard, this experiment has been conducted to develop reliable and selective detection and measurement methods by using static headspace (SH) isolation, followed by gas chromatography-mass spectrometry (GC-MS). A new method was developed for determining the spiked 1,4-dioxane contents in a polyethylene glycol 600 (PEG 600). The optimal condition for SH-GC-MS was discussed. The representative ions of 1,4-dioxane and 1,4-dioxane-d8 in the SIM mode of MS are 88 and 96, respectively, and the peaks of the SIM mode were separated and confirmed. The linear range for the method covers 0.25 to 100 mg/L with a coefficient of determination (R2) ≥ 0.999. The method applicability was demonstrated by spike recovery across a variety of food additives (i.e., chlorine bitartrate, choline chloride, polysorbate 20 and 60, and PEG 1000). All spike recovery from the tested samples was in the range of 89.50-102.68% with a precision of 0.44-11.22%. These findings suggest a new analytical method for food safety inspection, and could be applicable for ensuring the safety of foods and environmental and public health on a broad scale.

20.
Bioorg Med Chem ; 20(11): 3493-501, 2012 Jun 01.
Article in English | MEDLINE | ID: mdl-22543233

ABSTRACT

Licorice (Glycyrrhiza glabra, GG) is one of the most frequently used herbal medicines worldwide, and its various biological activities have been widely studied. GG is reported to have neurological properties such as antidepressant, anxiolytic, and anticonvulsant effects. However, its hypnotic effects and the mechanism of GG and its active compounds have not yet been demonstrated. In this study, GG ethanol extract (GGE) dose-dependently potentiated pentobarbital-induced sleep and increased the amount of non-rapid eye movement sleep in mice without decreasing delta activity. The hypnotic effect of GGE was completely inhibited by flumazenil, which is a well-known γ-aminobutyric acid type A-benzodiazepine (GABA(A)-BZD) receptor antagonist, similar to other GABA(A)-BZD receptor agonists (e.g., diazepam and zolpidem). The major flavonoid glabrol was isolated from the flavonoid-rich fraction of GGE; it inhibited [(3)H] flumazenil binding to the GABA(A)-BZD receptors in rat cerebral cortex membrane with a binding affinity (K(i)) of 1.63 µM. The molecular structure and pharmacophore model of glabrol and liquiritigenin indicate that the isoprenyl groups of glabrol may play a key role in binding to GABA(A)-BZD receptors. Glabrol increased sleep duration and decreased sleep latency in a dose-dependent manner (5, 10, 25, and 50mg/kg); its hypnotic effect was also blocked by flumazenil. The results imply that GGE and its flavonoid glabrol induce sleep via a positive allosteric modulation of GABA(A)-BZD receptors.


Subject(s)
Flavonoids/pharmacology , Glycyrrhiza/chemistry , Hypnotics and Sedatives/pharmacology , Plant Extracts/pharmacology , Receptors, GABA-A/metabolism , Animals , Dose-Response Relationship, Drug , Ethanol/chemistry , Eye Movements/drug effects , Flavanones/chemistry , Flavanones/pharmacology , Flavonoids/chemistry , Flavonoids/isolation & purification , Flumazenil/pharmacology , GABA-A Receptor Antagonists/metabolism , GABA-A Receptor Antagonists/pharmacology , Hypnotics and Sedatives/chemistry , Ligands , Mice , Mice, Inbred C57BL , Molecular Structure , Pentobarbital/pharmacology , Plant Extracts/chemistry , Plant Preparations , Sleep/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL